Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Talaris Therapeutics
93 Worcester St, Suite 120
Wellesley, MA 02481
https://talaristx.com/

Talaris Therapeutics, formerly Regenerex, is a late-clinical stage biotechnology company that is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. Talaris was founded on technology discovered and developed by Dr. Suzanne Ildstad and operates its own cell processing facility in Louisville, KY.

Key Contact
Name
Scott Requadt
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
04/18/19 $100,000,000 Series A Blackstone Life Sciences
Longitude Capital
Qiming Venture Partners
undisclosed
10/06/20 $115,000,000 Series B Aisling Capital
BlackRock
Blackstone Life Sciences
Cormorant Asset Management
Eventide Asset Management
Invus
Logos Capital
Longitude Capital
Pamoja Capital
Qiming Venture Partners
Surveyor Capital
Viking Global Investors
undisclosed